Industries > Pharma > Global Pharma Contract Sales Market 2018-2028

Global Pharma Contract Sales Market 2018-2028

Contract Detailing, Contract Non-Personal Promotion, Medical Education Services, Sample Management Services, Teledetailing Services, Edetailing Services

PUBLISHED: 31 January 2018
PAGES: 242
PRODUCT CODE: PHA0281

Clear
WOOCS 2.2.1
SKU: PHA0281 Categories: , ,

The global pharma contract sales market is expected to grow at a CAGR of 9.6% in the first half of the forecast period. The market is expected to grow at a CAGR of 7.9% from 2017-2028. The market is estimated at $5.48bn in 2017 and $9.48bn in 2023.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector. 

In this brand new 242-page report you will receive 90 tables and 65 figures– all unavailable elsewhere. 

The 242-page report provides clear detailed insight into the global pharma contract sales market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Pharma Contract Sales Market forecasts from 2018-2028

• Along with revenue prediction for the overall world market for pharma contract sales market, our investigation shows forecasts to 2028 for the following submarkets:
– Contract detailing (personal promotion/field sales)
– Contract non-personal promotion, with further sub-forecasting for teledetailing, eDetailing and others
– Medical education services
– Sample management services

This report also breaks down the revenue forecast for pharma contract sales market by therapeutic segments:
– Cardiovascular disease
– Metabolic disorders
– Cancer treatment
– Other 

• This report provides individual revenue forecasts to 2028 for these regional and national markets:
– USA
– Japan
– Germany, UK, France, Italy and Spain (EU5 countries)
– China, India, Brazil and Russia (BRIC group)

Global Pharma Contract Sales Market 2018-2028

• Our study discusses the SWOT and STEP factors of the global pharma contract sales market

• Our study discusses issues affecting the pharma contract sales industry and market from 2017:
– Outsourced and in-house sales reps – trends and emerging sales models, including multiple channels (multichannel marketing to medical professionals)
Services CSOs offer and benefits to drug companies outsourcing medical sales
– Maturing brands and product launches, including flexibility in field sales teams
Legislation and new market access requirements for pharma sales representatives 
– Changes to online marketing and potential for IT technologies Risk-sharing agreements
Key account management (KAM) and medical science liaison (MSL)

• This report discusses the leading companies in pharma contract sales

Visiongain’s study is intended for anyone requiring commercial analyses for the global pharma contract sales market. You find data, trends and predictions. 

Buy our report today Global Pharma Contract Sales Market 2018-2028: Contract Detailing, Contract Non-Personal Promotion, Medical Education Services, Sample Management Services, Teledetailing Services, Edetailing Services.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Pharma Contract Sales Market 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Pharma Contract Sales Market 2018-2028


Latest Pharma news

Visiongain Publishes Biopharmaceuticals Contract Manufacturing Market Report 2022-2032

Ageing population will be more susceptible to such diseases and is one of the key factors driving the growth of the global biological drugs market. In most of the developed world, the share of elderly population is almost touching a quarter of the population.

26 January 2022

READ

Visiongain Publishes Topical Drug Delivery Market Report 2022-2032

Some of the factors driving the market growth are the increasing prevalence of skin and eye diseases, high incidences of burn incidences and the growing prevalence of diabetes.

26 January 2022

READ

Visiongain Publishes Decentralized Clinical Trials Market Report 2022-2032

The growing adoption advanced e-clinical solutions, rising focus on clinical research, increasing investment in R&D, and adoption of decentralized clinical trials by biopharmaceutical companies are some of the major factors that drive the growth of the global decentralized clinical trials market.

24 January 2022

READ

Visiongain Publishes Nasal Drug Delivery Technology Market Report 2022-2032

The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.

18 January 2022

READ

Categories